Diabetes, obesity and hormone health
Metabolic medicine: glycemic management, GLP-1 therapeutics, thyroid disease and endocrine practice.
Endocrinology & Metabolism
The Endocrine Society advises against routine brain MRI for girls ages 6–8 and boys ages 8–9 with central precocious puberty and no neurologic signs.
Rayan Salih · September 25, 2026 · 6 min
Endocrinology & Metabolism
WHO is calling for stronger safety monitoring as GLP-1 use for weight loss grows worldwide. Clinicians need reliable prescribing, follow-up and adverse-event reporting systems.
Dr. Abu Bakar · 7 min read
Endocrinology & Metabolism
In a randomized trial, retatrutide monotherapy lowered glycated hemoglobin and body weight in adults with type 2 diabetes inadequately controlled by diet and exercise.
Dr. Abu Bakar · 6 min read
Endocrinology & Metabolism
REIMAGINE 3 found glycemic and weight benefits when cagrilintide-semaglutide was added to basal insulin in adults with type 2 diabetes. Hypoglycemia remains central to interpreting treatment escalation.
Dr. Abu Bakar · 6 min read
Endocrinology & Metabolism
The supporting systematic review favors aldosterone-directed treatment and clearer selection between adrenalectomy and medical therapy for adults with primary aldosteronism.
Rayan Salih · 7 min read
Endocrinology & Metabolism
The FDA has approved revised labeling for OTC orlistat (alli) warning of rare acute kidney injury, bringing kidney-risk messaging into line across US orlistat products.
Rayan Salih · 6 min read
Endocrinology & Metabolism
A secondary analysis found that finerenone reduced cardiovascular and kidney events across CKM stages in adults with type 2 diabetes and CKD, while favoring CKM stage regression over progression.
Dr. Abu Bakar · 7 min read
Endocrinology & Metabolism
Updated evidence supports SGLT inhibition across heart failure phenotypes, with the clearest benefit in preventing worsening heart failure. Mortality and safety findings require more nuanced interpretation.
Dr. Abu Bakar · 7 min read
Endocrinology & Metabolism
The FDA expanded teplizumab to patients ages 8–17 with stage 3 type 1 diabetes diagnosed within six weeks, based on evidence that it slows loss of insulin-producing function.
Rayan Salih · 7 min read
Endocrinology & Metabolism
Tirzepatide reduced apnea severity and body weight in adults with obesity and moderate-to-severe obstructive sleep apnea, supporting FDA approval with or without ongoing positive airway pressure therapy.
Egbavwe Pela · 7 min read
Endocrinology & Metabolism
Alcohol Use Disorder (AUD) represents one of the most persistent public health crises in modern medicine, driving severe
Rayan Salih · 9 min read
Endocrinology & Metabolism
In April 2026, the U.S. Food and Drug Administration (FDA) made a significant administrative adjustment in the regulation
Rayan Salih · 10 min read
Endocrinology & Metabolism
The rapid adoption of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) has fundamentally transformed the management of type 2
Rayan Salih · 8 min read
Endocrinology & Metabolism
The landscape of metabolic medicine has been fundamentally rewritten over the past decade by glucagon-like peptide-1 receptor agonists
Rayan Salih · 9 min read
Endocrinology & Metabolism
For more than a century, the clinical paradigm for managing newly diagnosed Type 1 Diabetes (T1D) has been
Rayan Salih · 7 min read
Endocrinology & Metabolism
The biopharmaceutical industry is undergoing a structural realignment that will directly shape clinical practice, formulary designs, and treatment
Rayan Salih · 7 min read
Endocrinology & Metabolism
The Trump administration has formally announced a delay of the Medicare Part D implementation of the Center for
Rayan Salih · 13 min read
Endocrinology & Metabolism
For the millions of patients with type 2 diabetes (T2D), lowering hemoglobin A1c (HbA1c) levels and maintaining the
Rayan Salih · 11 min read
Endocrinology & Metabolism
Telemedicine is bringing clinical interactions such as blood sugar monitoring to people with diabetes via the internet.
Dr. Abu Bakar · 13 min read
Endocrinology & Metabolism
Background: Central obesity is an emerging public health concern in Botswana with high prevalence among adults.
Dr. Abu Bakar · 12 min read
Endocrinology & Metabolism
As obesity medications become a routine component of clinical practice, individualized therapy has emerged as the central guiding
Rayan Salih · 7 min read
Endocrinology & Metabolism
There has been a “miracle drug” renaissance in recent years with a new generation of weight loss and
Dr. Abu Bakar · 15 min read
Endocrinology & Metabolism
The US Food and Drug Administration (FDA) completed labeling updates for Eli Lilly’s Zepbound (tirzepatide), a first-in-class combination
Rayan Salih · 4 min read
Endocrinology & Metabolism
With MHT again in the headlines on both benefits and risks for women, we’ll review the basics and
Rayan Salih · 3 min read
Endocrinology & Metabolism
Gut Linco Peptide-1 (GLP-1) medications have found a new “lease of life” as potential weight loss treatments.
Dr. Abu Bakar · 9 min read
Endocrinology & Metabolism
In recent years, several new medications for obesity and diabetes have entered the market, promising significant health benefits….
Rayan Salih · 8 min read
One story a day
One health journey each morning — no advice, no alarm, just company for the road.
